Subtopic Deep Dive
Topical Corticosteroids in Eosinophilic Esophagitis
Research Guide
What is Topical Corticosteroids in Eosinophilic Esophagitis?
Topical corticosteroids in eosinophilic esophagitis refer to swallowed formulations of fluticasone and budesonide used to treat esophageal eosinophilic inflammation.
Swallowed topical steroids target esophageal mucosa directly, achieving histologic remission in EoE patients. Key studies compare viscous budesonide to nebulized fluticasone, with Dellon et al. (2012) showing viscous forms superior (308 citations). Consensus guidelines by Liacouras et al. (2011, 2054 citations) and Furuta et al. (2007, 1664 citations) recommend them as first-line therapy.
Why It Matters
Topical corticosteroids provide rapid symptom relief and esophageal remodeling in EoE, serving as first-line therapy in guidelines (Liacouras et al., 2011). Dellon et al. (2012) demonstrated viscous topical therapy induces histologic remission in 82% of patients versus 32% with nebulized steroids, improving dysphagia scores. These agents reduce need for systemic biologics like dupilumab (Hirano et al., 2019), enabling long-term maintenance with minimized side effects.
Key Research Challenges
Optimizing Delivery Methods
Viscous formulations outperform nebulized steroids, but device variability affects esophageal coating (Dellon et al., 2012). Consensus lacks standardized delivery protocols across ages (Liacouras et al., 2011). Pediatric dosing remains inconsistent (Papadopoulou et al., 2013).
Long-term Maintenance Dosing
Induction achieves remission, but relapse occurs post-discontinuation without maintenance strategies (Furuta et al., 2007). Guidelines recommend ongoing therapy, yet optimal lowest effective doses are undefined (Liacouras et al., 2011).
Side Effect Monitoring
Candida esophagitis risk requires surveillance, with incidence varying by formulation (Dellon et al., 2012). Long-term safety data limited in children (Liacouras et al., 2005).
Essential Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
Chris A. Liacouras, Glenn T. Furuta, Ikuo Hirano et al. · 2011 · Journal of Allergy and Clinical Immunology · 2.1K citations
Eosinophilic Esophagitis in Children and Adults: A Systematic Review and Consensus Recommendations for Diagnosis and Treatment
Glenn T. Furuta, Chris A. Liacouras, Margaret H. Collins et al. · 2007 · Gastroenterology · 1.7K citations
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of the NIAID-Sponsored Expert Panel
Unknown, Joshua A Boyce, Amal Assa'ad et al. · 2010 · Journal of Allergy and Clinical Immunology · 1.2K citations
Eosinophilic Esophagitis: A 10-Year Experience in 381 Children
Chris A. Liacouras, Jonathan M. Spergel, Eduardo D. Ruchelli et al. · 2005 · Clinical Gastroenterology and Hepatology · 868 citations
Efficacy of Dietary Interventions for Inducing Histologic Remission in Patients With Eosinophilic Esophagitis: A Systematic Review and Meta-analysis
Ángel Arias, Jesús González‐Cervera, José María Tenías et al. · 2014 · Gastroenterology · 522 citations
Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis
Ikuo Hirano, Evan S. Dellon, Jennifer D. Hamilton et al. · 2019 · Gastroenterology · 432 citations
Epithelial cell–derived cytokines: more than just signaling the alarm
Florence Roan, Kazushige Obata‐Ninomiya, Steven F. Ziegler · 2019 · Journal of Clinical Investigation · 431 citations
The epithelial cell–derived cytokines thymic stromal lymphopoietin (TSLP), IL-33, and IL-25 are central regulators of type 2 immunity, which drives a broad array of allergic responses. Often charac...
Reading Guide
Foundational Papers
Start with Liacouras et al. (2011, 2054 citations) for consensus recommendations establishing topical steroids as first-line, then Furuta et al. (2007, 1664 citations) for initial systematic review.
Recent Advances
Study Dellon et al. (2012, 308 citations) for viscous vs nebulized comparison, and Papadopoulou et al. (2013) for pediatric guidelines.
Core Methods
Swallowed viscous budesonide slurries or fluticasone puffs target mucosa; efficacy measured by <15 eos/hpf post-therapy and symptom scores (Dellon et al., 2012).
How PapersFlow Helps You Research Topical Corticosteroids in Eosinophilic Esophagitis
Discover & Search
Research Agent uses searchPapers('topical corticosteroids eosinophilic esophagitis fluticasone budesonide') to find Dellon et al. (2012), then citationGraph reveals citing works on viscous formulations and exaSearch uncovers recent meta-analyses linking to Liacouras consensus (2011).
Analyze & Verify
Analysis Agent applies readPaperContent on Dellon et al. (2012) to extract remission rates (82% viscous vs 32% nebulized), verifies with runPythonAnalysis for meta-analysis of histologic outcomes using GRADE grading, and CoVe chain checks claims against Furuta et al. (2007).
Synthesize & Write
Synthesis Agent detects gaps in pediatric maintenance dosing from Liacouras et al. (2011), flags contradictions between nebulized vs viscous efficacy; Writing Agent uses latexEditText for guideline summaries, latexSyncCitations for 10+ papers, and latexCompile for EoE therapy review exportMermaid diagrams delivery methods.
Use Cases
"Compare remission rates of viscous budesonide vs fluticasone in EoE using meta-analysis."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis(pandas meta-analysis on Dellon 2012 + Arias 2014 data) → GRADE-verified remission rate table output.
"Draft LaTeX review section on topical steroid guidelines for EoE."
Synthesis Agent → gap detection (Liacouras 2011) → Writing Agent → latexEditText + latexSyncCitations(10 papers) + latexCompile → formatted PDF with citations.
"Find code for simulating EoE steroid dosing models from papers."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python dosing simulation scripts linked to Dellon 2012 pharmacokinetics.
Automated Workflows
Deep Research workflow scans 50+ EoE papers via searchPapers, structures topical steroid efficacy report with GRADE tables from Dellon et al. (2012). DeepScan applies 7-step CoVe to verify remission claims across Liacouras (2011) and Furuta (2007), checkpointing contradictions. Theorizer generates hypotheses on optimal viscous dosing from citationGraph clusters.
Frequently Asked Questions
What defines topical corticosteroids in EoE?
Swallowed fluticasone or budesonide formulations coat the esophagus to reduce eosinophilic inflammation, distinct from inhaled use (Liacouras et al., 2011).
What are key methods for topical steroid delivery?
Viscous slurries via puffers or oralvisc exceed nebulized MDIs; Dellon et al. (2012) report 82% histologic remission with viscous budesonide.
What are seminal papers on this topic?
Liacouras et al. (2011, 2054 citations) and Furuta et al. (2007, 1664 citations) provide consensus; Dellon et al. (2012, 308 citations) proves viscous superiority.
What open problems exist?
Standardized long-term dosing, pediatric delivery optimization, and candidiasis risk stratification lack resolution (Papadopoulou et al., 2013).
Research Eosinophilic Esophagitis with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Topical Corticosteroids in Eosinophilic Esophagitis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Eosinophilic Esophagitis Research Guide